Lymphocytic vasculitis of the uterus in a patient with melanoma receiving ipilimumab

J Clin Oncol. 2013 Jul 10;31(20):e356. doi: 10.1200/JCO.2012.47.5095. Epub 2013 Jun 3.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Biopsy, Needle
  • Female
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Infusions, Intravenous
  • Ipilimumab
  • Lymph Nodes / pathology*
  • Lymphatic Diseases / chemically induced*
  • Lymphatic Diseases / pathology
  • Lymphatic Metastasis
  • Lymphocytes / pathology
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Melanoma / secondary
  • Neoplasm Invasiveness / pathology
  • Rare Diseases
  • Remission Induction
  • Risk Assessment
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Uterus / blood supply
  • Uterus / drug effects*
  • Vasculitis / chemically induced*
  • Vasculitis / pathology

Substances

  • Antibodies, Monoclonal
  • Ipilimumab

Supplementary concepts

  • Vasculitis, Lymphocytic, Nodular